Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Pongprueth Rujirachun, Nipith Charoenngam, Phuuwadith Wattanachayakul, Arjbordin Winijkul, Weerapat Owattanapanich & Patompong Ungprasert. (2020) Efficacy and safety of direct oral anticoagulants (DOACs) versus vitamin K antagonist (VKA) among patients with atrial fibrillation and hypertrophic cardiomyopathy: a systematic review and meta-analysis. Acta Cardiologica 75:8, pages 724-731.
Read now
Read now
Articles from other publishers (13)
Samah W. Al-Jabi, Amal Abu Dalu, Amer A. Koni, Maher R. Khdour, Adham Abu Taha, Riad Amer & Sa’ed H. Zyoud. (2022) The relationship between self-efficacy and treatment satisfaction among patients with anticoagulant therapy: a cross-sectional study from a developing country. Thrombosis Journal 20:1.
Crossref
Crossref
Irene Criado Martin, Alba Mª Costa Grille & Roberto Petidier Torregrossa. 2022. Pathy's Principles and Practice of Geriatric Medicine. Pathy's Principles and Practice of Geriatric Medicine
307
315
.
Young-Soo Lee, Yong Seog Oh, Eue-Keun Choi, Alan Koay Choon Chern, Panyapat Jiampo, Aurauma Chutinet, Dicky Armein Hanafy, Prabhav Trivedi & Dongmei Zhai. (2021) Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study. Open Heart 8:2, pages e001745.
Crossref
Crossref
Shahrzad Salmasi, Adenike Adelakun, Abdollah Safari, Leanne Kwan, Jenny MacGillivray, Jason G. Andrade, Marc W. Deyell, Anita Kapanen & Peter Loewen. (2021) Satisfaction With Oral Anticoagulants Among Patients With Atrial Fibrillation: A Prospective Observational Study. CJC Open 3:11, pages 1347-1356.
Crossref
Crossref
Marijane Hynes. (2020) Beyond Ablation in Atrial Fibrillation: 10 Steps to Better Control. American Journal of Lifestyle Medicine 15:4, pages 434-440.
Crossref
Crossref
Vasyl Katerenchuk, Gonçalo S. Duarte, Gonçalo Martins e Pereira, Ricardo M. Fernandes, Joaquim J. Ferreira, Fausto J. Pinto, João Costa & Daniel Caldeira. (2020) Satisfaction of Patients with Nonvitamin K Anticoagulants Compared to Vitamin K Antagonists: a Systematic Review and Meta-analysis. Thrombosis and Haemostasis 121:03, pages 366-382.
Crossref
Crossref
Diana-Leh-Ching Ng, Natasya Marliana Bt Abdul Malik, Chee-Shee Chai, Greta-Miranda-Kim-Choo Goh, Seng-Beng Tan, Ping-Chong Bee, Gin-Gin Gan & Asri B. Said. (2020) Time in therapeutic range, quality of life and treatment satisfaction of patients on long-term warfarin for non-valvular atrial fibrillation: a cross-sectional study. Health and Quality of Life Outcomes 18:1.
Crossref
Crossref
Vivencio Barrios, Carlos Escobar, Juan José Gómez-Doblas, Jaime Fernández-Dueñas, Rafael Romero Garrido, Javier Pindado Rodríguez, Juana Umarán Sánchez, Eduardo Arellano-Rodrigo & Esther Donado. (2020) Patients’ perceptions with dabigatran in patients with atrial fibrillation previously treated with vitamin K antagonists. Journal of Comparative Effectiveness Research 9:9, pages 615-625.
Crossref
Crossref
Jasper H.A. van Miert, Hilde A.M. Kooistra, Nic J.G.M. Veeger, Annelies Westerterp, Margriet Piersma-Wichers & Karina Meijer. (2020) Quality of life after switching from well-controlled vitamin K antagonist to direct oral anticoagulant: Little to GAInN. Thrombosis Research 190, pages 69-75.
Crossref
Crossref
Manlio F. Márquez, Manuel A. Baños-González, Milton E. Guevara-Valdivia, Jorge Vázquez-Acosta, Manuel O. De los Ríos Ibarra, Julio A. Aguilar-Linares, Marcelo Jiménez-Cruz, Norberto Matadamas-Hernández, Rocío Camacho-Casillas, Reynaldo Magaña-Magaña, Ulises Rojel-Martínez, Marco A. Alcocer-Gamba, Susano Lara-Vaca, Humberto Rodríguez-Reyes, Marco A. Islava-Gálvez, Lidia E. Betancourt-Hernández, Nicolás Reyes-Reyes, Miguel E. Beltrán-Gámez, Carlos Cantú-Brito, Alberto Z. Baños-Velasco, Pedro J. Del Rivero Morfin & J. Antonio González-Hermosillo. (2020) Anticoagulation Therapy by Age and Embolic Risk for Nonvalvular Atrial Fibrillation in Mexico, an Upper-Middle-Income Country: The CARMEN-AF Registry. Global Heart 15:1, pages 32.
Crossref
Crossref
Saima Kishvar Afzal, Syed Shahzad Hasan & Zaheer Ud‐Din Babar. (2019) A systematic review of patient‐reported outcomes associated with the use of direct‐acting oral anticoagulants. British Journal of Clinical Pharmacology 85:12, pages 2652-2667.
Crossref
Crossref
M. Montero-Pérez-Barquero & L. Manzano. (2019) Quality of life, compliance and satisfaction of patients with atrial fibrillation who are undergoing anticoagulant treatment. Revista Clínica Española (English Edition) 219:6, pages 320-321.
Crossref
Crossref
M. Montero-Pérez-Barquero & L. Manzano. (2019) Calidad de vida, adherencia y satisfacción en pacientes con fibrilación auricular en tratamiento anticoagulante. Revista Clínica Española 219:6, pages 320-321.
Crossref
Crossref